We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$245M
AUM Growth
+$19.1M
Cap. Flow
+$9.86M
Cap. Flow %
4.03%
Top 10 Hldgs %
62.68%
Holding
339
New
38
Increased
42
Reduced
26
Closed
12

Top Buys

Rank Stock Value
1
NEAR icon
iShares Short Maturity Bond ETF
NEAR
+$5.09M
2
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$4.92M
3
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$1.03M
4
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$804K
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$536K

Top Sells

Rank Stock Value
1
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$4.8M
2
IUSG icon
iShares Core S&P US Growth ETF
IUSG
+$453K
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$251K
4
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$225K
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$211K

Sector Composition

Rank Sector Weight
1 Real Estate 1.7%
2 Technology 0.66%
3 Healthcare 0.63%
4 Financials 0.53%
5 Industrials 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QRVO icon
151
Qorvo
QRVO
$7.89B
$27K 0.01%
+410
New +$29.9K
ETY icon
152
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.32B
$26K 0.01%
2,168
– –
IGA
153
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
$26K 0.01%
2,310
– –
ABBV icon
154
AbbVie
ABBV
$433B
$24K 0.01%
243
– –
ETN icon
155
Eaton
ETN
$170B
$24K 0.01%
300
– –
REGN icon
156
Regeneron Pharmaceuticals
REGN
$78.2B
$24K 0.01%
+65
New +$26.3K
STLD icon
157
Steel Dynamics
STLD
$37B
$24K 0.01%
550
– –
BOE icon
158
BlackRock Enhanced Global Dividend Trust
BOE
$676M
$23K 0.01%
1,820
– –
DIS icon
159
Walt Disney
DIS
$170B
$23K 0.01%
214
– –
BPK
160
DELISTED
Blackrock Muni 2018 Term Tr
BPK
$23K 0.01%
1,554
– –
BDX icon
161
Becton Dickinson
BDX
$46.9B
$22K 0.01%
107
– –
CVS icon
162
CVS Health
CVS
$134B
$22K 0.01%
300
– –
IJR icon
163
iShares Core S&P Small-Cap ETF
IJR
$111B
$22K 0.01%
284
– –
NLSN
164
DELISTED
Nielsen Holdings plc
NLSN
$22K 0.01%
+610
New +$23.2K
CELG
165
DELISTED
Celgene Corp
CELG
$22K 0.01%
211
+144
+215% +$16.2K
GLD icon
166
SPDR Gold Trust
GLD
$131B
$21K 0.01%
172
– –
HDV
167
iShares Core High Dividend ETF
HDV
$14.8B
$21K 0.01%
1,190
– –
VGT icon
168
Vanguard Information Technology ETF
VGT
$141B
$21K 0.01%
1,000
– –
RDS.B
169
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$21K 0.01%
+304
New +$19.7K
HBAN icon
170
Huntington Bancshares
HBAN
$35.1B
$20K 0.01%
1,355
– –
ESRX
171
DELISTED
Express Scripts Holding Company
ESRX
$20K 0.01%
264
+215
+439% +$13.8K
BA icon
172
Boeing
BA
$185B
$19K 0.01%
65
– –
CTSH icon
173
Cognizant
CTSH
$24.9B
$19K 0.01%
270
– –
KMT icon
174
Kennametal
KMT
$2.66B
$19K 0.01%
400
– –
AZN icon
175
AstraZeneca
AZN
$245B
$18K 0.01%
260
– –
5 6
7
8 9

Similar funds

ICM
Innovator Capital Management Wheaton, Illinois $925M AUM 49.11% 1-Year Est. Return
TC
Tairen Capital Hong Kong $924M AUM 105.21% 1-Year Est. Return
CFA
Cahill Financial Advisors Edina, Minnesota $924M AUM 16.55% 1-Year Est. Return
MHIC
Marble Harbor Investment Counsel Boston, Massachusetts $923M AUM 14.09% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
GFG
Goldstone Financial Group Oakbrook Terrace, Illinois $922M AUM 14.34% 1-Year Est. Return
KI
Koch Inc Wichita, Kansas $922M AUM 16.65% 1-Year Est. Return
WC
Westerkirk Capital Victoria $929M AUM 21.93% 1-Year Est. Return

Roble Belko & Company's Q4 2017 Portfolio in Review

As of Q4 2017, Roble Belko & Company held 339 positions worth $245M, up 8.5% from $226M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Roble Belko & Company deployed $9.86M of net new capital in Q4 2017, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 6,721 shares worth $533K.

By sector, the portfolio is most concentrated in Real Estate at 1.7% of assets, up from 1.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Xtrackers MSCI EAFE Hedged Equity ETF, an estimated $4.8M trimmed.

  • Roble Belko & Company's largest Q4 2017 buy was Vanguard Short-Term Corporate Bond ETF: 6,721 shares worth $533K.
  • Roble Belko & Company added most to iShares Short Maturity Bond ETF in Q4 2017, an estimated $5.09M increase.
  • Roble Belko & Company's biggest Q4 2017 reduction was Xtrackers MSCI EAFE Hedged Equity ETF, cutting an estimated $4.8M.
  • Roble Belko & Company fully exited iShares Core S&P US Growth ETF in Q4 2017, selling an estimated $453K.
  • Roble Belko & Company's ten largest holdings make up 63% of its $245M portfolio in Q4 2017.
  • Roble Belko & Company opened 38 new positions and closed 12 in Q4 2017.
  • Roble Belko & Company's portfolio value rose 8.5% quarter-over-quarter to $245M.

Based on Roble Belko & Company's 13F filing for Q4 2017, filed 30 Jan 2018.